Eversight expands leadership team, names new board member

ANN ARBOR, Mich., — Eversight today announced an expansion to its leadership team and named a new member to its Board of Directors.

Collin Ross has been named vice president of Partner Relations & Global Development, overseeing Eversight’s domestic and international partnerships with surgeons, hospitals, government institutions and more. He has been with Eversight since 1997, leading the organization’s international efforts and building collaborative relationships with global partners. Ross has extensive expertise managing clinical and administrative projects, strategic plans and new programs and service lines. He holds a master’s degree from the University of Maryland School of Public Policy.

Ryan Simmons has been named vice president of Clinical Services, leading Eversight’s centralized operational departments that work closely with referring healthcare providers, donor families and organ procurement organizations to make possible sight-restoring donation, transplantation and research. He has built innovative forecasting models and led numerous process efficiency initiatives—including artificial intelligence integration—to provide ongoing improvements in service and quality. Simmons joined Eversight in 2010 and holds a master’s degree in supply chain management from the Eli Broad College of Business at Michigan State University.

Probi Kapur has been named to a three-year term on the Eversight Board of Directors effective Jan. 1, 2022. He is the senior vice president of IT Finance, Sourcing and Portfolio Management at AmerisourceBergen Corporation based in Pennsylvania. Kapur brings to the board a wealth of finance and business leadership experience in the pharmaceutical and healthcare industry. In his career, Kapur has led the financial operations of R&D, manufacturing, marketing, in-licensing, capital and strategic planning. He holds an MBA from Boston University.

"We congratulate Collin and Ryan on their new leadership roles and welcome Probi to the board," said Diane Hollingsworth, Eversight president/CEO. "Collin and Ryan contribute a combined 37 years of eye banking experience to the leadership team, and Probi lends exceptional pharmaceutical and healthcare industry expertise. With the continued strength of our leadership team and our diverse governing Board of Directors, Eversight will continue delivering on its mission to restore sight and prevent blindness by empowering people and transforming lives."

Serving in leadership positions on the 2022 Board of Directors are Patty Jo Herndon, chair; Katheryne L. Zelenock, vice chair; Danielle E. D’Arcy, treasurer; and Mahmoud N. Ghazzi, M.D., Ph.D., secretary. Visit eversightvision.org/leadership for more information about the Eversight leadership team and Board of Directors.

About Eversight

Eversight is a nonprofit organization with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. The Eversight network is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. Operating in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, Eversight works in collaboration with surgeons, researchers, academic medical centers and eye banks across the United States and abroad. For more information, visit eversightvision.org.

Media Contact

Mackenzie Mohr

Communications Director

(517) 204-1413